Concepedia

Author

R Nissinen

Helsinki University Hospital

Also Known As

B Salzberg, E Zhuleku, R Nissinen, R. Nissinen, Riikka Nissinen

43

Publications

541

Citations

10

H-Index

11

Concepts

All Affiliations

Helsinki University HospitalInstitute for Molecular Medicine FinlandUniversity of HelsinkiESiOR Oy (Finland)Statens Serum Institut
RN

About

R Nissinen is an author at Helsinki University Hospital specializing in medicine, psoriatic arthritis, and gastroenterology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

29

2

Public Health

1

1

18

3

Epidemiology

1

1

18

4

Gastroenterology

1

1

11

5

Clinical Epidemiology

1

1

18

R Nissinen

×

11

Publications

490

Citations

10

H-Index

YearCitations

Mechanisms of Coxsackievirus-Induced Damage to Human Pancreaticβ -Cells<sup>1</sup>

Merja Roivainen, Suvi Rasilainen, Petri Ylipaasto,

The Journal of Clinical Endocrinology & Metabolism

2000

166

Pregnancy Outcomes Reported During the 13-Year TREAT Registry: A Descriptive Report

Gary R. Lichtenstein, Brian G. Feagan, Uma Mahadevan,

The American Journal of Gastroenterology

2018

75

Cytokine and chemokine receptor profile of peripheral blood mononuclear cells during treatment with infliximab in patients with active rheumatoid arthritis

R Nissinen

Annals of the Rheumatic Diseases

2004

48

Ustekinumab for Crohn’s disease: a nationwide real-life cohort study from Finland (FINUSTE)

Anja Eberl, Taru Hallinen, Clas-Göran af Björkesten,

Scandinavian Journal of Gastroenterology

2019

47

Peptidylarginine deiminase, the arginine to citrulline converting enzyme, is frequently recognized by sera of patients with rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren syndrome

R Nissinen, Leena Paimela, Heikki Julkunen,

Scandinavian Journal of Rheumatology

2003

43

CCR3, CCR5, interleukin 4, and interferon-gamma expression on synovial and peripheral T cells and monocytes in patients with rheumatoid arthritis.

R Nissinen, Marjatta Leirisalo‐Repo, Minna Tiittanen,

PubMed

2003

29

Immune activation in the small intestine in patients with rheumatoid arthritis

R Nissinen

Annals of the Rheumatic Diseases

2004

23

Objectively assessed disease activity and drug persistence during ustekinumab treatment in a nationwide real-world Crohn’s disease cohort

Clas-Göran af Björkesten, Tuire Ilus, Taru Hallinen,

European Journal of Gastroenterology & Hepatology

2020

20

Guselkumab Treatment Outcomes and Persistence in a Nationwide Real-world Cohort of Patients with Plaque Psoriasis

Tarja Mälkönen, Pauliina Nuutinen, Taru Hallinen,

Acta Dermato Venereologica

2021

18

Mo1800 Risk Factors for Serious Infections in Elderly Patients Receiving Infliximab and Other Crohn's Disease Therapies: TREAT™Registry Data

Gary R. Lichtenstein, Wayne Langholff, Brian G. Feagan,

Gastroenterology

2016

11

Page 1